SCHEMBL30284344

SCHEMBL30284344

Cc1cccc(-c2cccc(C(O)C(=O)N3CCc4nc(C5(c6ccccc6)CC5)[nH]c(=O)c4C3)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ MTHFD2 P13995 9/20 0.42
▸ CDK4 P11802 3/20 0.37
▸ CCND1 P24385 3/20 0.37
▸ CLPP Q16740 1/20 0.37
▸ ABCB1 P08183 1/20 0.33
▸ DGAT2 Q96PD7 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ SPR P35270 1/20 0.33
▸ BRD4 O60885 1/20 0.33
▸ CREBBP Q92793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23972479 1.00 MTHFD2 (0.42) MTHFD2CDK4CCND1CLPPABCB1
SCHEMBL23973671 0.96 MTHFD2 (0.42) MTHFD2CDK4CCND1CLPPSPR
SCHEMBL30283932 0.95 MTHFD2 (0.41) MTHFD2CLPPDGAT2KDRSPR
SCHEMBL23972726 0.95 MTHFD2 (0.41) MTHFD2CLPPDGAT2KDRSPR
SCHEMBL23972480 0.94 MTHFD2 (0.42) MTHFD2CDK4CCND1CLPPSPR
SCHEMBL30284456 0.94 MTHFD2 (0.42) MTHFD2CDK4CCND1CLPPSPR
SCHEMBL23972477 0.94 MTHFD2 (0.45) MTHFD2SPRBRD4CREBBP
SCHEMBL30284343 0.93 MTHFD2 (0.40) MTHFD2CDK4CCND1CLPPSPR
SCHEMBL23973346 0.93 MTHFD2 (0.40) MTHFD2CDK4CCND1CLPPSPR
SCHEMBL23973666 0.93 MTHFD2 (0.43) MTHFD2SPRBRD4CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4142874-B1 PYRIMIDIN-4(3H)-ONE DERIVATIVES AS TRPV4 ANTAGONISTS RAQUALIA PHARMA INC (JP) 2026-04-22 — — EP claimed
CN-115427409-B Pyrimidine-4 (3H) -one derivatives as TRPV4 antagonists 拉夸里亚创药株式会社 2025-02-25 — — CN claimed
CN-115427409-B Pyrimidine-4 (3H) -one derivatives as TRPV4 antagonists 拉夸里亚创药株式会社 2025-02-25 — — CN disclosed
CN-115776890-A TRPV4 inhibitors as therapeutic agents for eye diseases 拉夸里亚创药株式会社 2023-03-10 — — CN disclosed
Send feedback